In low-grade gliomas compared to non-neoplastic brain tissue, the ratio of pro-BDNF to mature-BDNF was reduced by 17%, while for GBM, the reduction was 44%, explaining GBM aggressiveness and its invasive nature [95]. The gene discussed is BDNF; the disease is central nervous system cancer.